Compounds for inhibiting mitotic progression

Details for Australian Patent Application No. 2012203952 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Claiborne, Christopher F.; Sells, Todd B.; Stroud, Stephen G.

Agent Davies Collison Cave

Pub. Number AU-A-2012203952

Parent 2007322046

Filing date 5 July 2012

Wipo publication date 26 July 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 Antineoplastic agents

Event Publications

19 July 2012 Complete Application Filed

26 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203952

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203953-Stilbene derivatives and their use for binding and imaging amyloid plaques

2012203951-A socket with a shutter